Correlation Between Suzhou Novoprotein and Fujian Longzhou

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Fujian Longzhou at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Fujian Longzhou into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Fujian Longzhou Transportation, you can compare the effects of market volatilities on Suzhou Novoprotein and Fujian Longzhou and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Fujian Longzhou. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Fujian Longzhou.

Diversification Opportunities for Suzhou Novoprotein and Fujian Longzhou

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Suzhou and Fujian is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Fujian Longzhou Transportation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fujian Longzhou Tran and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Fujian Longzhou. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fujian Longzhou Tran has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Fujian Longzhou go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Fujian Longzhou

Assuming the 90 days trading horizon Suzhou Novoprotein is expected to generate 2.0 times less return on investment than Fujian Longzhou. But when comparing it to its historical volatility, Suzhou Novoprotein Scientific is 1.3 times less risky than Fujian Longzhou. It trades about 0.07 of its potential returns per unit of risk. Fujian Longzhou Transportation is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  365.00  in Fujian Longzhou Transportation on September 24, 2024 and sell it today you would earn a total of  88.00  from holding Fujian Longzhou Transportation or generate 24.11% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.36%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Fujian Longzhou Transportation

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.
Fujian Longzhou Tran 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fujian Longzhou Transportation are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Fujian Longzhou sustained solid returns over the last few months and may actually be approaching a breakup point.

Suzhou Novoprotein and Fujian Longzhou Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Fujian Longzhou

The main advantage of trading using opposite Suzhou Novoprotein and Fujian Longzhou positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Fujian Longzhou can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fujian Longzhou will offset losses from the drop in Fujian Longzhou's long position.
The idea behind Suzhou Novoprotein Scientific and Fujian Longzhou Transportation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance